Lv51
970 积分 2022-04-22 加入
Dual-payload ADCs move into first oncology clinical trials
6小时前
待确认
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
12天前
已完结
Long-term outcomes of IgA nephropathy in China
1个月前
已完结
Past and present discovery of the BAFF/APRIL system – A bibliometric study from 1999 to 2023
1个月前
已完结
Gastric cancer
2个月前
已完结
The race to reset autoimmune diseases
2个月前
已完结
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
3个月前
已完结
Trends in the drug target landscape for autoimmune diseases
3个月前
已完结
Exploring the next generation of antibody–drug conjugates
4个月前
已完结
Systemic Lupus Erythematosus: A Review
4个月前
已完结
皖公网安备34019202002308
